stockrowAlcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) Revenue
Alcon's revenue for fiscal 2025 was $10.4B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $10.9B. Over the past ten years it has ranged from $6.4B (fiscal 2016) to $10.4B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. Alcon ranks 5th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $10.4B | 4.94% |
| FY2024 | $9.9B | 4.82% |
| FY2023 | $9.5B | 8.47% |
| FY2022 | $8.7B | 5.14% |
| FY2021 | $8.3B | 21.34% |
| FY2020 | $6.8B | (8.99%) |
| FY2019 | $7.5B | 4.96% |
| FY2018 | $7.2B | 4.86% |
| FY2017 | $6.8B | 7.08% |
| FY2016 | $6.4B | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $2.8B | 4.32% |
| Mar 2026 | $2.7B | (0.44%) |
| Dec 2025 | $2.7B | 3.98% |
| Sep 2025 | $2.6B | 0.69% |
| 28 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| MDLN Medline Inc. compare | $30.7B |
| BDX Becton, Dickinson and Company compare | $20.8B |
| BAX Baxter International Inc. compare | $11.6B |
| ALC Alcon | $10.9B |
| SOLV Solventum Corporation compare | $8.2B |
| RMD ResMed Inc. compare | $5.7B |
| COO The Cooper Companies, Inc. compare | $4.2B |
| ALGN Align Technology, Inc. compare | $4.2B |
| WST West Pharmaceutical Services, Inc. compare | $3.4B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on ALC
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement